Two more pharmas practice their Accent, invest in $75M series C round

Two more pharmas practice their Accent, invest in $75M series C round

Source: 
Fierce Biotech
snippet: 

Accent Therapeutics has reeled in investments from two more pharmaceutical companies as part of a $75M series C, the latest validation for the RNA drug developer.